26 Mar, 2014

Spago Imaging AB presents data on new MR contrast agent Spago Pix at ECR in Vienna.

Spago Imaging visited the radiology meeting ECR in Vienna to present data on the Spago Pix, a nanosized polymeric manganese-containing contrast agent. As shown by MR-analysis as well as chemical analysis and immunohistochemistry in a clinically relevant mouse model of breast cancer, Spago Pix selectively leaks into tumor tissue where it demonstrates excellent tumor contrast enhancement. Spago Pix thus shows great potential as a macromolecular MR contrast agent for tumor detection. Download the poster by following the link below. Strong tumor MR contrast enhancement with novel nanomaterial in an oncogene-driven breast cancer model_ECR2014